Registry study for heart PYP scans in possible ATTR amyloidosis
Part of Brain & nervous system, Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.
This study collects information from adults who have been diagnosed with, or are being checked for, ATTR amyloidosis (a condition where abnormal protein builds up in the body) using a heart PYP scan. Your participation may help doctors better understand how these scans relate to diagnosis and follow-up over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 20 years old
- You have a confirmed diagnosis or are being ruled out for ATTR amyloidosis
- You cannot be pregnant or breastfeeding
- You should not have serious other illnesses that are expected to limit life to under 6 months
- You must agree to clinical follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how often a specific heart condition (ATTR amyloid) occurs in people age 65+ who have HFpEF. It also tries to predict who might have it, using a special heart scan, and may help your care team identify it earlier.
This study looks back at bone scans that were done for other reasons to see if they can spot a condition called cardiac amyloidosis, where abnormal protein builds up in the heart.
This trial is looking at leftover tissue from past spine surgeries to see if it contains signs of a heart condition called TTR amyloidosis. It may help find people who have this condition early.
This study looks at how a type of heart condition called transthyretin cardiac amyloidosis changes over time, using a special imaging test called a bone scan. The goal is to see if the scan can help track the disease and potentially improve care.
This trial is testing a special PET/CT scan (Pan-Amyloid) that finds abnormal protein deposits (amyloid) in the heart and body. It is for people who have or may have cardiac amyloidosis and are already planning to get this scan.
This study tests whether taking a small tissue sample from the right side of the heart during a routine pacemaker or defibrillator procedure can help find a condition called cardiac amyloidosis, which causes stiffening of the heart muscle. It aims to improve early detection in people who already need a cardiac device and may have early signs of the disease.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.